osimertinibpelcitoclaxCohort 1Cohort 3NSCLCCohort 2
…cell lymphoma-2 (BCL-2)/BCL-extra-large (BCL-xL) inhibitor, and osimertinib in patients with EGFR-mutated advanced NSCLC.Methods Enrolled p…
1articles mentioning drugs
4drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: pelcitoclax ×
pelcitoclax
This drug is selected. Its supporting articles are shown below.